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T lymphocytes participate in many immunologic functions. For example, they 
may become cytotoxic cells (Tc), ~ exert helper (TH) or suppressor (Ts) effects on 
antibody  production,  or  trigger  the  inflammatory response  of delayed-type 
hypersensitivity (DTH) (TD). Recently, it has been demonstrated (1, 2) that some 
of the T  cells involved in these functions may be characterized by their cell 
surface antigens. The Ly (2) and Ia (3) alloantigens have been especially useful 
in  this  regard.  Thus  cytotoxic and  suppressor  functions  are  diminished by 
treatment with anti-Ly-2 serum, but not by anti-Ly-1 serum  (4,  5),  whereas 
helper functions are sensitive to anti-Ly-1 serum, but not to anti-Ly-2 serum (2). 
Treatment with anti-Ia serum has been reported to diminish helper and sup- 
pressor functions, but not cytotoxic functions (3). In this paper we report that the 
cells responsible for DTH are similar to TH in their Ly phenotypes but, unlike 
some primed helper cells, are Ia negative. 
Materials and Methods 
Mice.  2- to 3-mo-old specific pathogen-free CBA/CaHWehi, BALB/c An Bradley  Wehi,  and 
C57BL/6J Wehi mice were used.  The mice used for antisera  production  were: AKR/J, A.TH*, 
A.TL*,  B10.PL(7S)NS*,  (B10.AKM  ×  129)F~*, C57BL/6-Ly-1 ~*,  and  (C57BL/6  ×  LP.RIII)Fz*. 
These mice were obtained from either The Jackson Laboratory, Bar Harbor, Maine or from Dr. D. 
Shreffler, Department of Human Genetics, University of Michigan, Ann Arbor, Mich. The strains 
marked with an asterisk were obtained from Dr. M. Cherry, The Jackson Laboratory. 
Antigens.  Erythrocytes from sheep (SRBC) and horse (HRBC) were obtained from the Com- 
monwealth Serum Laboratories  (CSL), Melbourne, Australia.  Fowl gamma globulin (FGG) was 
obtained as described before (6) and human gamma globulin (HGG)  (Cohn fraction no.  11) was 
purchased from CSL. These proteins were diluted in normal saline to the appropriate concentra- 
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tion before use. Deaggregated HGG (deHGG) was prepared according to the method of Basten et 
al.  (7).  DNP~HGG and DNPIsFGG were prepared as described previously (8). 
Sensitization Procedures.  For the production of high levels of DTH, mice were treated with 200 
mg/kg of cyclophosphamide (Endoxan, Asta; Mead Johnson, Crows Nest, Australia) (9) subcuta- 
neously 2 days before giving 400/~g of FGG (in 0.1 ml) emulsified in complete Freund's adjuvant 
(CFA) (Difco Laboratories, Detroit, Mich. ) into the two hind foot pads and subcutaneously into the 
abdomen. Mice were primed to HGG by injecting 500 ~g alum-precipitated antigen (10) intraperi- 
toneally with 2  ×  109 Bordetella pertussis  organisms (Pertuesis vaccine, 4  ×  10  TM organisms/ml; 
CSL). In the case of dinitrophenylated antigens, 100 ~g DNP-HGG or 30/zg DNP-FGG was given 
in the soluble form intraperitoneally,  l0  s HRBC  were injected intravenously into each mouse. 
Mice were tolerized to HGG by the intravenous injection of 2.5 mg of deHGG (7). 
Cell Suspensions.  Lymph  nodes  were  removed  and  cell  suspensions  prepared  by  teasing 
organs through a stainless steel wire mesh into Eisen's balanced salt solution. They were washed 
three times, counted, and their viability estimated by an eosin-dye exclusion method. 
DTHAssay.  This is described in detail elsewhere (11). Briefly this assay measures the influx 
of  cells  labeled  with  125I-5-iodo-2'-deoxyuridine  (125I-UdR)  into  DTH  lesions.  Conventionally, 
antigen is deposited into the left (L) pinna and the right (R) remains uninjected. 24 h later the ears 
are cut off and the ratio of the radioactivity in the L/R ears reflects the extent of DTH. To increase 
labeling efficiency 10 -7 moi of 5-fluorodeoxyuridine is injected intraperitoneally 20 min before 125I- 
UdR. 
Assay for Plaque-Forming Cells (PFC's).  PFC's were assayed by the technique of Cunningham 
and  Szenberg  (12).  Indirect  (IgG)  PFC's  were  developed  by  the  addition  of rabbit-antimouse 
immunoglobulin serum to the cell mixture. This antiserum did not suppress direct (IgM) PFC's. 
Cytotoxicity Assay.  This method has been described in detail by Burton et al.  (13).  Briefly 
responder spleen cells are cultured in vitro with irradiated stimulator cells for 6 days. The cells are 
harvested and added to target cells labeled with 5~Cr. The release of 51Cr into the supernate after a 
period of time is proportional to the number of cytotoxic lymphocytes added, and to the number of 
target cells lysed. Percent specific lysis is calculated by the formula: 
51Cr release in experiment -  background 
×  100; 
maximal releasable ~Cr -  background 
where background is the release of 51Cr from target cells in the absence of immune lymphocytes 
and maximal releasable 51Cr is the amount released  when labeled target cells are lysod with 
detergent. 
Radioisotopes and Radiometry.  125I-UdR,  sp act 90-110 ~Ci/~g, 5~Cr (sodium chromate, sp act 
50-200 ~Ci/~g CEA, Gif-Sur-Yvette, France) was used as described before (13). 
Production of Antisera 
ANTI-Ly-I.I,  ANTI*Ly*2.1 AND  ANTI-Ia l,  2,  3,  7.  Thymus cells  (1 donor per 10 recipients) were 
used for immunization for the Ly antisera, and thymus, lymph node, and spleen cells for the Ia 
antisera. Intraperitoneal injections were given weekly for 6-8 wk and thereafter every 2 wk. In the 
weeks between immunizations, the mice were bled and the sera collected and pooled. Sera were 
absorbed by mixing them with thymocytes (10 thymuses/ml serum) for 30 min at 4°C in order to 
remove autoantibody. The strains and sources of the mice used for the production and absorption 
of these sera are shown in Table I. 
ANTI-Ly-I.2 AND 2.2.  These sera were prepared by Dr. Shen as described in reference 14. 
ANTI-Thy-1 SERUM.  This was raised in AKR/J mice as described previously (15). 
COMPLEMENT (C).  Rabbits were bled, their serum separated and tested for C activity. Batches 
were selected for low cytotoxicity against mouse thymocytes and high C activity. When necessary 
the serum was absorbed with mouse thymocytes before use. 
Treatment of Cells with Antisera 
ANTI-Ly-I.1 AND 2.1 AND  ANTI-Ia.  To  1 ml of cells at a  concentration of 1.5  x  10S/ml,  1 ml of 
antiserum was added to a  final concentration of 1:10 for anti-Ly-l.l,l:4 for anti Ly-2.1, and 1:100 
for anti-Ia, and the cells left at room temperature for 30 min, washed twice, and resuspended in 
rabbit C at a final concentration of 5 x  10S/ml.  They were then incubated for 30 rain at 37°C and 12  Ly  AND  Ia  ANTIGENS  ON  T  CELLS 
washed  three  times  before  use.  The  concentrations of sera  used  were  those  which  lysed  the 
maximum number of cells as determined by previous cytotexic assays. 
ANTI-Ly-I.2, 2.2.  Anti-Ly-l.2, 2.2 is described in detail elsewhere (14). 
ANTI-Thy-1.  Anti-Thy-1 was used as previously described (15). 
Specificity ofLy Antisera.  The Ly antisera were raised between strains of mice congenic for 
the Ly-1 and Ly-2 loci (Table I) and should contain no additional specificities other than autoanti- 
body. This appeared to be the case as both sera reacted as expected: cells from CBA, C3H, DBA/1, 
and DBA/2 strains and the appropriate donors were positive when reacted with both antisera; 
C57BL/6, A, BALB/c, and 129 were negative. 
Results 
Effect of Anti-Ly and Anti-Ia Sera on the Transfer of DTH by Lymph Node 
Cells.  Lymph node  cells from cyclophosphamide-pretreated  CBA mice  were 
taken  5 days after immunization  with FGG.  The cells were divided into five 
aliquots of l0 s viable cells each and were given the following treatment: (a) anti- 
Ly-l.1 serum and C; (b) anti-Ly-2.1 serum and C; (d) anti-Ia serum and C; (e) C 
only; and (f)  no treatment.  Each aliquot was then injected intravenously into 
five naive CBA mice which were ear-challenged  immediately with FGG.  The 
ability of these cells to transfer DTH was assessed by the radioisotopic ear assay. 
The results are shown in Table II. Incubation with C alone, anti-Ia serum and C, 
or anti-Ly-2.1 serum and C did not decrease the ability of the cells to transfer 
DTH, whereas anti-Ly-l.1 serum and C abolished it. The enhanced capacity of 
anti-Ly-2.1 serum-treated cells to transfer DTH (Table II) was observed in three 
out of six such experiments. 
To check if anti-Ly-l.2 and anti-Ly-2.2 sera had similar effects we immunized 
C57BL mice with  FGG as described above and  treated  the lymph node cells 
obtained 5 days later in the following ways: (a)  anti-Ly-l.2  serum and C; (b) 
anti-Ly-2.2  serum  and  C; (c)  C  alone;  and  (d)  no treatment.  The results  are 
shown in Table III. Again anti~Ly-l.2 serum but not anti-Ly-2.2 serum inhibited 
the transfer of DTH. 
These results suggest that the Ly phenotype of T, cells is the same as that 
reported for TH (1, 2,  5). They do, however, differ in their sensitivity to anti-Ia 
serum  (see  below).  We  have  previously  found  that  lymph  node  cells  from 
animals sensitized to give maximal DTH can also exert helper functions. Thus it 
was possible for us to compare directly the effect of antiserum treatment on the 
same population of lymph node cells that had the potential to transfer these two 
T-cell functions. 
Effect of  Anti-Ly and Anti.Ia Sera on the Helper Activity of Sensitized Lymph 
Node Cells.  Lymph node cells were taken from the same CBA animals  that 
were used for DTH experiments. Aliquots of l0 T  viable cells were treated in the 
following ways: (a)  anti-Ly-l.1 serum and C; (b)  anti-Ly-2.1 serum and C; (c) 
anti-Ia serum and C; (d) C alone; and (e) no treatment.  Each aliquot was then 
transferred into six syngeneic, lethally irradiated mice together with l0  s HRBC 
and 5  ×  l0  s anti-Thy-1 serum-treated spleen cells from CBA mice primed with 
DNP-polymerized flagellin  (POL) 2 mo previously. The animals were given 30 
~g of DNP-FGG intraperitoneally,  and 7 days later the spleens were taken and 
assayed  for  anti-HRBC  PFC  and  anti-DNP  PFC  (as  DNP-Fab-SRBC).  The 
results are shown in Table IV. Treatment with anti-Ly-l.1  serum and anti-Ia VADAS  ET  AL.  13 
TABLE  I 
Production, Absorption, and Cytotoxicity  Titers of Anti-Ly-1.1, Anti-Ly-2.1, Anti-Ia, 
and Anti-Thy-1 Sera 
Specificity of  Donor of immu-  Origin of cells used 
antiserum  nizing cells  Recipients  for absorption 
Cytotoxicity  titers 
Thymus  Lymph  node  Spleen 
Ly-l.1  C57BL/6-Ly-1" (C57BL/6  x  LP.RIII)F~  C57BL/6 thymus  1/256  1/4,192  1/4,192 
Ly-2.1  B6.PL(75NS)  (B10.AKM  x  129)F~  C57BL/6 thymus  1/256  1/32  1/128 
Ia-1,2,3,7  A.TL  A.TH  A.TH thymus  0  1/5,000  1/5,000 
Thy-l.2  CBA  AKR  Krebs II ascites  ND  1/32  ND 
TABLE  II 
Effect of Anti-Ly and Anti-Ia Sera on the Transfer of DTH by CBA Lymph Node 
Cells 
No. of  sensitized  lymph 
node cells  transferred be- 
fore  treatment 
Antiserum treatment  L/R~2sI-UdR uptake 
0  -  1.25 +_ 0.09* 
15 x  106  -  2.19 _+ 0.12 
15 x  l0  s  C  1.86 ___ 0.13 
15 x  106  Anti-Ly-l.1 + C  1.21 _+ 0.05 
15 x  106  Anti-Ly-2.1 + C  2.75 _+ 0.13 
15 x  10  s  Anti-Ia + C  1.79 _+ 0.15 
* ixMean _+ one SEM, five mice per group. 
TABLE  III 
Effect of Anti-Ly Sera on the Transfer of DTH by C57BL Lymph Node Cells 
No. of  sensitized  lymph 
node cells  transferred (be- 
fore  treatment) 
Antiserum treatment  L/R~2~I-UdR uptake 
0  -  1.31 _+ 0.13" 
12 × 106  -  3.11 __ 0.21 
12 ×  106  C  2.61 _+ 0.26 
12 × 106  Anti-Ly-l.2 + C  1.30 +__ 0.18 
12 x  106  Anti-Ly-2.2 + C  2.23 _ 0.08 
*Mean _+ one SEM. Four to five mice per group. 
serum but not with anti-Ly-2.1 serum markedly inhibited the helper activity of 
these cells in terms of anti-DNP antibody production to DNP-FGG. 
Before firm conclusions could be reached about the Ly and Ia phenotypes of T, 
and TH cells, it was important to demonstrate that our anti-Ly-1.1 serum did not 
delete all T-cell functions, and that our anti-Ly-2.1 and anti-Ia sera were indeed 
effective against some T-cell functions. These experiments are described below. 
Effect  of Anti-Ly  Sera  on  the Activity  of Cytotoxic  T  Lymphocytes  In  Vi- 
tro.  To induce cytotoxic lymphocytes, CBA spleen cells were  incubated with 
irradiated BALB/c spleen cells in vitro. After 6 days of incubation the cells were 
collected, washed three times, and divided into eight equal aliquots which were 
treated  in the  following ways:  (a)  no  treatment;  (b)  C  only; (c)  anti-Ly-l.1 14  Ly  AND  Ia  ANTIGENS  ON  T  CELLS 
TABLE  IV 
Effect of Anti-Ly Serum on the Helper Activities of Sensitized Lymph Node Cells 
No. of cells trans- 
ferred into lethally ir- 
radiated* recipients 
together with 10  s 
HRBC* 
DNP- 
POL-  FGG- 
primed  primed 
spleen  lymph 
cells  node 









PFC per spleen at 7 days 
Anti-DNP 
Direct  Indirect  Indirect 
anti- 
HRBC 
5 × 106  None  -  30 (3.3)§  150 (1.6)  0 
5  ×  106  2  ×  106  -  2,600 (1.2)  6,600 (1.3)  50 (2.7) 
5 × 106  2 × 106  Anti-Ly-l.1  + C  170 (3.7)  290 (4.3)  450 (1.4) 
5 × 106  2 × 106  Anti-Ly-2.1  + C  750 (1.3)  9,700 (1.1)  560 (1.4) 
5 × 106  2 × 106  C alone  1,300 (1.5)  16,600  (1.2)  150 (2.9) 
5  ×  106  2  ×  106  Anti-Ia  + C  190 (2.4)  340 (1.7)  100 (3.1) 
* 850 R 4 h before transfer. 
30/~g DNP-FGG was given intraperitoneally  at the same time. HRBC as 0.1 ml of 5% suspen- 
sion. 
§ Geometric means and SEM (number in parentheses denotes factor which multiplies and divides 
the mean to give the upper and lower limits of the SEM). Six mice per group. Numbers of direct 
HRBC PFC were less than 20 per spleen in all groups. 
serum; (d) anti-Ly-2.1 serum; (e) anti-Thy-1 serum; (f) anti-Ly-1.1 serum plus C; 
(g)  anti-Ly-2.1 serum plus C; and (h)  anti-Thy-1 serum plus C.  The cytotoxic 
activity of these various aliquots against WEHI-164 is shown in Table V. Anti- 
Thy-1 serum and C  reduced this activity to 6%.  Anti-Ly-2.1 serum and C  and 
anti-Ly-1.1 serum and C  reduced the cytotoxicity, but the reduction was more 
marked  with  anti-Ly-2.1 serum  and  C  (16  vs.  26%).  When BALB/c cytotoxic 
lymphocytes were  treated  in  an  identical  manner  there  was  no  evidence  of 
abrogation of cytotoxic activity with anti-Ly-1.1 and anti-Ly-2.1 sera  (data not 
shown). 
Effect of Anti-Ly and Anti-Ia Sera on the Suppressor Activity of Spleen Cells 
from HGG-Tolerant Mice.  Spleen cells taken from CBA mice injected 14 days 
previously with 2.5 mg of deHGG provide a  source of T-cell-dependent suppres- 
sor cells  (7).  When these cells were  mixed with HGG-primed spleen cells and 
DNP-primed B cells and given to lethally irradiated syngeneic recipients chal- 
lenged with  DNP-HGG and HRBC,  specific suppression can be demonstrated 
(see groups 1-4 in Table VI and reference 7).  Groups 5-8 in Table VI show the 
effect of the treatment  of the  suppressor population with Ly and Ia antisera. 
Groups 9-12 show the PFC's resulting when the same antisera were used on the 
HGG-primed population. Three points can be made about the results obtained. 
Anti-Ia  serum  was  effective  in  diminishing  the  suppressive  effect  of HGG- 
tolerant cells  (group 7) but not the helper activity of HGG-primed cells  (group VADAS  ET  AL. 
TABLE  V 
Effect of Treatment with Anti-Ly Sera on CBA Cytotoxic Cells 
Antiserum treatment of cells*  % Cytotoxicity on WEHI-1645 
None  38  _+  2§ 
C  36_+0 
Anti-Ly-l.1  37  _+  1 
Anti-Ly-2.1  34  _+  1 
Anti-Thy-i  35  _+  2 
Anti-Ly-l.1 +  C  26  _+  2 
Anti-Ly-2.1 +  C  16  _+  2 
Anti-Thy-1 +  C  6  _+  1 
* Cytotexic cells  were  incubated  with  target  for 4  h  at  a  cytotoxic 
lymphocyte:target ratio of 20:1. Cell numbers were not adjusted for 
differential viability resulting from antiserum treatment. 
WEHI-164 is a  BALB/c fibrosarcoma. 
§ Mean +  one SEM. Assay done in triplicate. 
15 
11).  Anti-Ly-l.1  serum,  in spite of its powerful capacity to abolish the helper 
activity of HGG-primed cells (group 9), had no significant effect on the suppres- 
sors (group 5).  Anti-Ly-2.1 serum treatment  partially removed the suppressor 
effect (group 6), while helper function was left intact (group 10). Suppressor cells 
induced in vivo in this system can therefore be characterized as Ly-l-, probably 
Ly-2  + and Ia +. 
Discussion 
Ly antisera  have  been very useful in characterizing  the subsets of T  cells 
required for helper  (TH) and cytotoxic (Tc) functions.  When CBA lymph node 
cells were treated with anti-Ly-l.1 serum and C their ability to transfer DTH 
was abolished.  Anti-Ly-2.1 serum and C  did not however affect this function. 
The phenotype of TD cells is therefore Ly-1 +,2-. It was important to demonstrate 
that the anti-Ly-1 serum did not ablate all T-cell functions and, as a  corollary, 
that anti-Ly-2.1 serum was effective against other T-cell types. This was done in 
two different ways. When cytotoxic cells were treated with antisera, anti-Ly-1.1 
serum had only a mild effect, and anti-Ly-2.1 serum a stronger inhibitory effect 
(Table  V).  Similarly  the  suppressor  effect of HGG-tolerant  spleen  cells  was 
unaffected  by  anti-Ly-l.1  serum,  but  was  partially  inhibited  by anti-Ly-2.1 
serum. 
Although the Ly-1.1 and 2.1 antisera were raised in congenic mice, and were 
always absorbed for autoantibody, their specificity for the appropriate allele was 
demonstrated in two ways. Firstly, when these sera were tested against BALB/c 
cytotoxic cells, there was no killing or diminution of function. Secondly, when 
the  sera were absorbed with thymus cells from  C57BL Ly congenic mice the 
appropriate anti-Ly activity was removed. 
In order to make a  general statement about the Ly phenotype of T, cells we 
tested the effect of anti-Ly-l.2 and anti-Ly-2.2 sera on sensitized C57BL cells. In 
this system T, cells were also Ly-l+,2 -. This serum was raised by Shen et al. in 
the Memorial-Sloan Kettering Cancer Center, New York, and was confirmed to 
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We  have  provided  evidence  that  Ly  antisera  are  useful in  characterizing 
functional subsets of CBA T cells and that effector cells mediating DTH in CBA 
mice have Ly-l÷,2  -  phenotypes.  This is the same Ly phenotype which we and 
others  (1,  2,  5) have found on TH cells.  There is other evidence for similarity 
between the TD and TH cells. Cells taken from mice which were pretreated with 
cyclophosphamide and immunized with FGG in CFA in order to exhibit maxi- 
mal DTH, were as powerful helpers as cells taken from mice immunized with 
FGG in CFA only, which exhibit very weak or no DTH. In addition,  the cells 
responsible for helper and DTH function, although easily separable from other 
lymphoid cells by sedimentation velocity,  2 cannot be separated from one another 
by this method.  There are,  however, several apparent  differences between T, 
and  TM  cells.  For  example,  using  simple  immunization  regimes  there  is  an 
inverse relationship between the ability of some antigens to immunize mice to 
generate helper cell function or DTH (16). Similarly these cells are different in 
their  susceptibility to  tolerogenesis  (17).  These  differences  may reflect  func- 
tional  restrictions  affecting  identical  cells  (e.g.,  an  inhibition  of rapid  local 
antigen  recognition).  Alternatively,  these cells may in fact belong to distinct 
subsets. 
Ia  antigens,  although  most densely represented  on  B  cells  (18),  have  been 
detected  in  small  quantities  on  some  T  cells  (19-21).  Despite  this  meager 
representation,  treatment with anti-Ia serum and C has been shown to inhibit 
certain T-cell functions. The Ts cell responsible for allotype suppression (3) and 
in  some instances  the  TH cell  (3) have been inhibited  by anti-Ia  sera and  C. 
These findings suggested that Ia antisera, like Ly, may be helpful in defining T- 
cell  subsets.  Our  results  confirmed  the  sensitivity  of suppressor  cells  to  Ia 
antisera with a different system. The suppressor activity in this system depends 
on two cell types: one,  anti-Thy-1  sensitive;  the other retained  by an  anti-Ig 
column  (7). When  these  two  populations  of cells  are  mixed  the  suppressor 
activity is restored (7). Anti-Ia treatment of the purified T cells (tolerant spleen 
cells passed through  an  anti-Ig column) abolishes their ability to restore sup- 
pressor activity to the mixture  (J. R. Gamble, M. A. Vadas, J. F. A. P. Miller, 
and A. Basten, unpublished observation). Thus it seems that Ts cells are Ia ÷. TH 
cells could also be inhibited by anti-Ia serum, but only when limiting numbers of 
recently primed helper cells from cyclophosphamide-pretreated mice were used 
(Tables IV and VI).  The T, cells,  by contrast,  were not at all sensitive.  This 
might suggest that TH and TD cells in fact belong to different cell populations. It 
is,  however,  not  clear  what  Ia  antigens  represent  on  T  cells.  They  may  be 
passively absorbed onto a subset of T cells (22) or, as suggested by Parish et al. 
(23),  T  cells  may  secrete  Ia  antigens.  Alternatively,  it  is  possible that  the 
macrophage is the source of Ia antigens  [or Ia-antigen complex like the geneti- 
cally related factor (GRF) of Erb et al.  (24)] which are absorbed onto lymphoid 
cells.  Interestingly,  a  very high  proportion  of recirculating  lymphocytes from 
irradiated  mice in which T cells had been activated to histocompatibility anti- 
gens are Ia positive (25). Cells activated to FGG in a similar manner have in our 
hands  repeatedly failed to  initiate  DTH responses.  This  may imply that  the 
2 Vadas, M. A., and J. M. Fidler. Manuscript in preparation. 18  Ly  AND  Ia  ANTIGENS  ON  T  CELLS 
surfaces of such cells are blocked by Ia-antigen complexes (e.g., GRF). The cells 
would thus be unable to recognize antigen in a  site where this was deposited to 
elicit DTH. 
Summary 
The Ly and  Ia phenotypes of T  lymphocytes involved in different functions 
were characterized by the use of specific antisera. T cells responsible for delayed- 
type hypersensitivity (DTH) and for helper functions were found to be Ly-l+,2 - 
in contrast to cytotoxic T cells and T cells responsible for suppression of antibody 
responses  which  were  Ly-l-,2  ÷.  Unlike  some primed  helper  cells,  T  cells  in- 
volved in DTH were Ia-. Suppressor cells in the system studied were Ia  ÷. 
Received for publication 7 April 1976. 
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